Prescribing errors in hospital inpatients: their incidence and clinical significance

被引:261
作者
Dean, B
Schachter, M
Vincent, C
Barber, N
机构
[1] Univ London, Sch Pharm, Dept Practice & Policy, London WC1N 1AX, England
[2] Univ London Imperial Coll Sci Technol & Med, Sch Med, London, England
[3] UCL, Clin Risk Unit, London WC1E 6BT, England
[4] Univ London, Sch Pharm, Dept Practice & Policy, London WC1N 1AX, England
来源
QUALITY & SAFETY IN HEALTH CARE | 2002年 / 11卷 / 04期
关键词
D O I
10.1136/qhc.11.4.340
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: It has been estimated that 1-2% of US inpatients are harmed by medication errors, the majority of which are errors in prescribing. The UK Department of Health has recommended that serious errors in the use of prescribed drugs should be reduced by 40% by 2005; however, little is known about the current incidence of prescribing errors in the UK. This pilot study sought to investigate their incidence in one UK hospital. Methods: Pharmacists prospectively recorded details of all prescribing errors identified in non-obstetric inpatients during a 4 week period. The number of medication orders written was estimated from a I in 5 sample of inpatients. Potential clinical significance was assessed by a pharmacist and a clinical pharmacologist. Results: About 36 200 medication orders were written during the study period, and a prescribing error was identified in 1.5% (95% confidence interval (CI) 1.4 to 1.6). A potentially serious error occurred in 0.4% (95% CI 0.3 to 0.5). Most of the errors (54%) were associated with choice of dose. Error rates were significantly different for different stages of patient stay (p<0.0001) with a higher error rate for medication orders written during the inpatient stay than for those written on admission or discharge. While the majority of all errors (61%) originated in medication order writing, most serious errors (58%) originated in the prescribing decision. Conclusions: There were about 135 prescribing errors identified each week, of which 34 were potentially serious. Knowing where and when errors are most likely to occur will be helpful in designing initiatives to reduce them. The methods developed could be used to evaluate such initiatives.
引用
收藏
页码:340 / 344
页数:5
相关论文
共 24 条
[1]  
[Anonymous], 2001, SPOONF SUG MED MAN N
[2]  
Barber N, 1993, Qual Health Care, V2, P3, DOI 10.1136/qshc.2.1.3
[3]  
Barber N, 1998, CLIN RISK, V4, P103
[4]   Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom [J].
Barber, ND ;
Batty, R ;
Ridout, DA .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (04) :397-405
[5]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[6]  
Batty R, 1992, Qual Health Care, V1, P5, DOI 10.1136/qshc.1.1.5
[7]   MEDICATION ERROR PREVENTION BY PHARMACISTS [J].
BLUM, KV ;
ABEL, SR ;
URBANSKI, CJ ;
PIERCE, JM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (09) :1902-1903
[8]   SURVEY OF CLINICAL PHARMACY SERVICES IN UNITED-KINGDOM NATIONAL-HEALTH-SERVICE HOSPITALS [J].
COTTER, SM ;
BARBER, ND ;
MCKEE, M .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (21) :2676-2684
[9]  
Cousins D, 1991, INT J PHARM PRACT, V1, P86
[10]   Learning from prescribing errors [J].
Dean, B .
QUALITY & SAFETY IN HEALTH CARE, 2002, 11 (03) :258-260